← Leaderboards
Dimitra Peppa
University Of Oxford
$1,931,617
Attributed
$1,931,617
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $476.1K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,931,617 · 1
By mechanism
R01$1,931,617 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Hiv Infections”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Kevin Urdahl · Seattle Children'S Hospital$73,163,231
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Bambra Strokes · Ppd Development Lp$65,000,267
Research focus
Hiv InfectionsAntibodiesHepatitis B VirusHigh RiskBloodCd8-Positive T-LymphocytesCell PhysiologyFine Needle Aspiration BiopsyHepaticGenetic TranscriptionClinical MaterialClinical TrialsCohortCo-InfectionCytokineEffective TherapyCellsAutologousAntiretroviral TherapyEnv Gene ProductsChronicExhaustionExhibitsImmune
Grant awards (5)
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication$327,448
R01 · FY2024 · AI · contact PI
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication$335,613
R01 · FY2023 · AI · contact PI
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication$342,227
R01 · FY2022 · AI · contact PI
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication$450,259
R01 · FY2021 · AI · contact PI
Exploiting Natural Killer cells in HIV/HBV co-infection to achieve eradication$476,070
R01 · FY2020 · AI · contact PI